Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD

Indacaterol is a long-acting inhaled beta(2)-agonist (LABA) for the treatment of chronic obstructive pulmonary disease (COPD). In previous studies, indacaterol provided 24 h bronchodilation on once-daily dosing with a fast onset of action. This study compared the efficacy and safety of indacaterol w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thorax 2010-06, Vol.65 (6), p.473-479
Hauptverfasser:	Dahl, Ronald, Chung, Kian Fan, Buhl, Roland, Magnussen, Helgo, Nonikov, Vladimir, Jack, Damon, Bleasdale, Patricia, Owen, Roger, Higgins, Mark, Kramer, Benjamin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Agonists - administration & dosage Adrenergic beta-Agonists - therapeutic use Aged Bronchodilator Agents - administration & dosage Bronchodilator Agents - therapeutic use Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Ethanolamines - administration & dosage Ethanolamines - therapeutic use Female Forced Expiratory Volume - drug effects Formoterol Fumarate Humans Indans - administration & dosage Indans - therapeutic use Male Middle Aged Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - physiopathology Quinolones - administration & dosage Quinolones - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!